New combo attack: radiation & immune drug aim to prime Body's defenses before chemo in breast cancer
NCT ID NCT07188246
Summary
This study is testing a new treatment sequence for high-risk breast cancer. It aims to see if giving a short, targeted radiation treatment along with an immune-boosting drug directly into the tumor can better prepare the body's immune system before starting standard chemotherapy. The goal is to improve the chances of eliminating all detectable cancer cells by the time of surgery. The trial is recruiting 40 adults with stage 2B or 3 breast cancer who are planning to have chemotherapy before surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Joseph's Health Care London
NOT_YET_RECRUITINGLondon, Ontario, N6A 4V2, Canada
-
St. Joseph's Health Care London
RECRUITINGLondon, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.